Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/LABORATORY-CORPORATION-OF-13392/news/Labcorp-kundigt-Erweiterung-des-Portfolios-fur-Prazisionsonkologie-an-um-die-pharmazeutische-bi-46398862/?utm_source=whatsapp&utm_medium=social&utm_campaign=share